Autoimmune diseases are a diverse and complex set of chronic disorders with a substantial
impact on patient quality of life and a significant global healthcare burden. Current …

Accumulating evidence indicates that most primary Wharton's jelly mesenchymal stem cells
(WJ-MSCs) therapeutic potential is due to their paracrine activity, ie, their ability to modulate …

Over the past decade, there had been progress in the development of cell therapy for insulin-
dependent diabetes. Nevertheless, important hurdles that need to be overcome still remain …

Abstract Type 1 diabetes (T1D) is a chronic autoimmune disease associated with
complications that reduce the quality of life of affected individuals and their families. The …

Type 1 Diabetes (T1D) is a chronic autoimmune disease characterized by a gradual
destruction of insulin-producing β-cells in the endocrine pancreas due to innate and specific …

Introduction: Stem cells can be used to treat diabetic mellitus and complications. ω3-
docosahexaenoic acid (DHA) derived lipid mediators are inflammation-resolving and …

Type 1 diabetes is an autoimmune disease affecting genetically predisposed individuals that
leads to chronic hyperglycemia. It is well established that the disease progresses through …

Immune checkpoint inhibitors (ICIs) have become extensively utilized in the early-stage
treatment of various cancers, offering additional therapeutic possibilities for patients with …

Aims Evidence is accumulating of the therapeutic benefits of mesenchymal stromal cells
(MSCs) in diabetes‐related conditions. We have identified a novel population of stromal …

To investigate the safety and efficacy of the islet-like cell (cell) induced from human umbilical
cord mesenchymal stem cell (UCMSC) with different methods for the treatment of diabetic …